DSM Biologics to Acquire Rhobust Technology from Danish Firm
04:30 AM | May 5, 2010 | Deepti Ramesh
DSM Biologics says it has reached an agreement with biotech company Upfront Chromatography (Copenhagen, Denmark) for the acquisition of the assets and associated business of Rhobust technology for...
This information is only available to subscribers.
chemweek.com is the one stop platform for chemical news, data and analysis across all industry sectors and geographies.